- Talk to us 1300 437 386|Contact us
- NDSS Helpline 1800 637 700
Not a member? JOIN NOW to access exclusive member benefits!
Having trouble? Visit our Online Help section
2 March 2021
Urgent Product Defect Correction: Dexcom CGM Systems
Dexcom recently became aware that hydroxyurea, an anti-neoplastic drug used primarily in chemotherapy, falsely elevates glucose readings on Dexcom CGM systems. This may result in failure to treat hypoglycaemia from missed low sensor glucose values and alerts or by causing other errors in diabetes management decisions.
